Clinical trials, also known as clinical studies, test potential treatments in human volunteers to see whether they should be approved for wider use in the general population. A treatment could include a drug, medical device, or biologic, such as a vaccine, blood product, or gene therapy. Potential treatments must be studied in laboratory animals first to determine potential toxicity before they can be tried in people. Treatments having acceptable safety profiles and showing the most promise are then moved into clinical trials. (FDA.gov)
Clinical trials offer a unique opportunity to patients and medical professionals. These trials are a way of testing potential treatments for conditions such as brain tumor, while making new or experimental treatments available to qualified brain tumor patients. Clinical trials involve patient participation, so the effectiveness of the tested treatment(s) can be accurately gauged.
If you decide that you are interested in participating in a clinical trial, it is important to review all of the materials relative to the clinical trial, with a caregiver if possible, and with your doctor and to ask your doctor about any questions or concerns you may have.
National Institute of Health
To learn more about clinical trials, visit NIH Clinical Research Trials and You
American Brain Tumor Association
To access TrialConnect, a service of the American Brain Tumor Association that links brain tumor patients with potential clinical trials, visit the ABTA's website on Brain Tumor Clinical Trials.
A registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details.
Recently diagnosed with a brain tumor? Have questions or need support? Contact us today.